欧盟EMA药品数据库(European Medicines Agency Authorisation of Medicines DataBase)
商品名称Certifect
适用类别Veterinary
治疗领域
通用名/非专利名称fipronil / amitraz / (S)-methoprene
活性成分fipronil;amitraz;(S)-methoprene
产品号EMEA/V/C/002002
患者安全信息No
许可状态Withdrawn
ATC编码QP53AX65
是否额外监管No
是否仿制药或hybrid药物No
是否生物类似药No
是否附条件批准No
是否特殊情形No
是否加速审评No
是否罕用药No
上市许可日期2011/05/06
上市许可开发者/申请人/持有人Merial
人用药物治疗学分组
兽用药物治疗学分组Ectoparasiticides for topical use, incl. insecticides
欧盟委员会决定日期2016/04/18
修订号5
治疗适应症Treatment and prevention of infestations in dogs by ticks (Ixodes ricinus, Dermacentor reticulatus, Rhipicephalus sanguineus, Ixodes scapularis, Dermacentor variabilis, Haemaphysalis elliptica, Haemaphysalis longicornis, Amblyomma americanum and Amblyomma maculatum) and fleas (Ctenocephalides felis and Ctenocephalides canis). Treatment of infestations by chewing lice (Trichodectes canis). Prevention of environmental flea contamination by inhibiting the development of all flea immature stages. The product can be used as part of a treatment strategy for the control of flea-allergy dermatitis. Elimination of fleas and ticks within 24 hours. One treatment prevents further infestations for five weeks by ticks and for up to five weeks by fleas. The treatment indirectly reduces the risk of transmission of tick-borne diseases (canine babesiosis, monocytic ehrlichiosis, granulocytic anaplasmosis and borreliosis) from infected ticks for four weeks.
适用物种Dogs
兽用药物ATC编码QP53AX65
首次发布日期2016/04/18
最后更新日期2018/07/27
产品说明书https://www.ema.europa.eu/en/documents/product-information/certifect-epar-product-information_en.pdf
公共评估报告https://www.ema.europa.eu/en/medicines/veterinary/EPAR/certifect
©2006-2025 DrugFuture->European Medicines Agency Authorisation of Medicines DataBase